Dr Ray Page Details Using Triage Pathways and Scaling Them Across Multiple Practices
https://www.ajmc.com/interviews/dr-ray-page-details-using-triage-pathways-and-scaling-them-across-multiple-practices
https://www.ajmc.com/interviews/dr-ray-page-details-using-triage-pathways-and-scaling-them-across-multiple-practices
Shah CP1, Mramba LK2, Bishnoi R1, Unnikrishnan A3, Duff JM1,4, Chandana SR5,6,7. https://www.ncbi.nlm.nih.gov/pubmed/31602324
-“IMFINZI is first immunotherapy to show both significant survival benefit and improved, durable responses in extensive-stage small cell lung cancer”, presented at WCLC plenary…
Zhao W, Liu Y, Jenkins BD, Cheng R, Harris BN, Zhang W, Xie J, Murrow JR, Hodgson J, Egan M, Bankey A, Nikolinakos PG, Ali…
Weiss JM1, Csoszi T2, Maglakelidze M3, Hoyer RJ4, Beck JT5, Gomez MD6, Lowczak A7, Aljumaily R8, Lima CMR9, Boccia RV10, Hanna W11, Nikolinakos P12, Chiu…
Yardley DA1, Hart L2, Favret A3, Blau S4, Diab S5, Richards D6, Sparano J7, Beck JT8, Richards P9, Ward P10, Ramaswamy B11, Tsai M12, Blackwell…
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer:…
QCCA Winter 2020 Leadership Summit, March 18-20, The Wigwam, Litchfield Park, AZ. For more information, please contact: Info@QCCA.us.com
QCCA Summer 2019 Leadership Summit, September 4-6, 2019, JW Marriott, Grand Rapids, MI. For more information, please contact: Info@QCCA.us.com